Chief Medical Officer · Adaptive Biotechnologies Corp (ADPT)

Lance Baldo

FY2019 is the first fiscal year CompBrief holds for Lance Baldo as a named executive officer of Adaptive Biotechnologies; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$3,707,390

Salary $311,490Stock awards $0Bonus $237,500

1st of 5 named executive officers at Adaptive Biotechnologies by FY2019 total.

5 named officers on file for Adaptive Biotechnologies, FY2019

Lance Baldo’s pay file — $29

  • 1 fiscal year of pay, line by line
  • ADPT’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Adaptive Biotechnologies’s whole pay program stands against its peers

  • Adaptive Biotechnologies’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ADPT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 24, 2020 (DEF 14A).

Free

Get Lance Baldo’s full pay file as a PDF — free

More than this page: up to 10 years of Lance’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Lance Baldo compensation by year

Adaptive Biotechnologies Summary Compensation Table · the one fiscal year held
In US dollars, as Adaptive Biotechnologies reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019
Salary$311,490
Bonus$237,500
Stock awards$0
Option awards$3,158,400
Non-equity incentive$0
Pension and deferred compensation$0
All other$0
Total$3,707,390

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Adaptive Biotechnologies Corp DEF 14A filed April 24, 2020, accession 0001564590-20-018506, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Adaptive Biotechnologies Corp filed document, accession 0001564590-20-018506. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2020.

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
Option500,000—$7.80

Per the Outstanding Equity Awards at Fiscal Year-End table in Adaptive Biotechnologies Corp's FY2019 proxy; value at the fiscal year-end close, as the company printed it.

Adaptive Biotechnologies’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Lance Baldo · this pageChief Medical Officer$3,707,390
Chad RobinsChief Scientific Officer$2,856,181
Harlan RobinsChief Scientific Officer$2,647,022
Julie RubinsteinPresident$1,709,560
Chad CohenChief Financial Officer$1,130,027

The full Adaptive Biotechnologies compensation record

free company brief

This page is one person within Adaptive Biotechnologies's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Adaptive Biotechnologies proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Adaptive Biotechnologies's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Lance Baldo's compensation dossier · One-time report. No refunds.